2:30 Scalpel Street (kid show)

Today, brain surgery on Big Birdie

3:00 Hollywood Scars

Contestants try to determine
what disease they are being
exposed to

3:30 What's My Spine

Actors and their ailments

4:00 Scar Trek

The crew is swallowed by
a pancreas

5:00 The Gallstones (cartoon)

Fred and Bernie discover fire,
the wheel, and CB radio

6:00 I've Got A Secretion

Malaria and typhoid today

6:30 Name That Prune

Game show with new wrinkle

[LC]

7:00 **Ailment In The Family**

Archie learns his head is hollow

7:30 **The Malpractice**

Doc's patients include a schizoid-paranoid, a nymphomaniac, and a penguin

8:00 **Ferry With A Syringe**
**On Top (movie)**

Wild West adventure about tribal medicine man

9:30 **Welcome Back, Kidney**

Teacher learns his class has dissected the principal

10:00 **Attack Of The Gastro-Intestinal**
**People (movie)**

Set in Africa. Easy to follow, hard to swallow

NOW...
get plenty of rest
and get well soon!

FROM THE BOSTON UNIVERSITY DENTAL
STUDENT WHO MET YOU AT THE
BOSTON AIRPORT SUNDAY. BEST REGARDS
TO YOUR WIFE NANCY. PLEASE GET
WELL SOON!

JOANNE TOBIAS

HENRY A. KISSINGER

March 19, 1982

Dear Mrs. Tonkins:

I appreciated your card which I received while I was hospitalized. Your thoughtfulness and good wishes meant a great deal to me.

HENRY A. KISSINGER

July 12, 1982

Dear Mr. Townley:

Please forgive my very belated thank-
you for the card you sent to me when
I was hospitalized earlier this year.
Your thoughtfulness and good wishes
meant a great deal to me.

# Crew of Columbia
traveled with Anusol

HOUSTON, TEX.—If nothing else, the two astronauts who flew into space last month aboard the space shuttle Columbia didn't have to worry about treating hemorrhoids—if they happened to suffer an attack of that painful aftight while orbiting the earth.

National Aeronautics and
Space Administration (NASA)
officials secured a number of
physician's sample size tubes
of Warner-Lambert's Anusol-HC
hemorrhoidal cream on the ad-
vice of a Houston hospital. The
cream was included in the medi-
cal kit issued to astronauts John
Young and Robert Crippen,
notes George Rohrmann, senior
product manager, Parke-Davis
Group.

Unusual stresses

"According to the NASA offi-
cial I spoke with, if an astronaut
has a predilection for 'hemor-
rhoids he or she is very likely to
experience problems due to the
G-forces and other stresses ex-
erted on the body when exiting
and reentering the earth's atmo-
sphere," says Rohrmann.

With cap and special appli-
cator included, the sample size

tube of Anusol-HC weighs only
eight to nine grams. That's evi-
dently "just what the doctor
ordered," as far as NASA is con-
cerned, since they must justify
the addition of every gram of
weight added to the shuttle's
payload.

Space agency officials have
told Rohrmann that they will
include Anusol-HC in medical
kits on future shuttle flights pro-
viding the company continues to
manufacture the small tubes.

"This is an excellent example of the positive effects of sales force activities," notes Rohrmann. "You never really know where a product sample will end up—even in outer space."

NASA took every possible medical precaution in preparing for first space shuttle flight, including sending Anusol aloft with shuttle astronauts John Young (left) and Robert Crippen.

Company provides grant to program
to spur women onto technical careers

ANN ARBOR, MICH.—Students, faculty members and the scientific community at large will all benefit from a $15,000 gift Warner-Lambert recently made to the Women in Science Program co-sponsored by the University of Michigan's Center for

Continuing Education of Wom-
en and the school's science
departments.

The Women in Science Pro-
gram encourages women to pur-
sue majors and careers in math-
ematics, science and technical
fields. Warner-Lambert's gift is

expected to benefit them by pro-
moting the exchange of scien-
tific information and ideas and
providing needed role models
for both students and faculty
members.

The funding will be used over
the next two years to sponsor
lectures by visiting women sci-
entists and one or two universi-
ty-wide lectures by outstanding
women scientists during each of
those years, according to Dr.
Barbara F. Sloat, coordinator of
the Women in Science Program.

"Warner-Lambert is pleased to be able to help advance the cause of women professionals, particularly in science, our area of greatest investment and interest," notes Dr. Jerry A. Weisbach, president of the company's Pharmaceutical Research Division, which is headquartered in Ann Arbor adjacent to the University of Michigan.

Patent life
hinders R&D

NORTH PLATTE, NEB.—Reforms in the drug patent law are needed to bring “newer, more effective drugs to the marketplace faster to benefit patients sooner,” President and Chief Operating Officer Joseph D. Williams recently told a group of pharmacists.

Speaking at the Centennial
Convention of the Nebraska
Pharmaceuticals Association here,
Mr. Williams said that the cur-
rent patent law is hindering re-
search and development produc-
tivity in the pharmaceutical
industry.

Mr. Williams cited figures to show that the effective patent life of a new drug had been reduced nearly 50 percent in the last 20 years due to increased regulation and a lengthy federal review process.

He suggested two alternatives
to solve the problem: either be-
gin the 17-year patent life at
the time of government approval to
market a new drug, or add a
fixed number of years to the
patent to compensate for the
review process.

Drug research appears to be
on the threshold of a new golden
age because, Mr. Williams said,
"we know more than ever be-
fore about how the human body
functions, how disease is caused
and what chemical compounds
interfere with or enhance physi-
ological processes."

He said there are promising
new drugs on the horizon to
treat heart disease, cancer, cen-
cral nervous system disorders,
life-threatening infections and
diseases of old age.

In addition, Mr. Williams told
the pharmacists that new devel-
opments in fiber optic endo-
scopes, cardiovascular catheters
and lasers are helping to "create
new surgical techniques, far re-
moved from earlier practices."

Marlowe, Siegel
get R&D posts

Edward Marlowe, Ph.D., has
been appointed vice president-
research and development for
the Consumer Products Group.
Concurrent with Dr. Marlowe
joining Warner-Lambert, Shel-
don Siegel has assumed new re-
sponsibilities as vice president-
worldwide technology for CPG.

In his new capacity Dr. Mar-
lowe is responsible for the ad-
ministration, supervision, plan-
ning and overall operation of
CPG research and development
activities, process and packag-
ing engineering and clinical and
regulatory affairs.

Dr. Marlowe has extensive ex-
perience in consumer products
research and development. He
most recently served as vice-
president-research and develop-
ment with the Plough division
of Schering. He previously held
other key R&D positions with
American Home Products, the
Ortho division of Johnson &
Johnson and Merck.

Dr. Marlowe holds B.S. and
M.S. degrees in pharmaceutical
science from Columbia Univer-
sity. He obtained his Ph.D. in
pharmaceutical chemistry from
the University of Maryland. He
is also active in the scientific
community and currently serves
as vice chairman of the Sci-
entific Affairs Committee of The
Proprietary Association.

Siegel will be responsible for
coordinating CPG research and
development activities world-
wide and serving as a primary
resource for introducing world-
wide technology to CPG's U. S.-
based R&D effort. He will report
to Dr. Marlowe.

Siegel holds a B.S. from Long
Island University, an M.S. from
Columbia and an M.B.A. from
Fairleigh Dickinson.

Update

News of interest to
Warner-Lambert employees

* A test for breast cancer will be the next blockbuster product to hit the home diagnostic market, say industry analysts. The tests could help propel the $100 million market, which was born with the home pregnancy test, into a $400 million giant by 1985.

* Under the fresh leadership of a new commissioner, the Food and Drug Administration is apt to make some serious new attempt at reducing the time it takes for a New Drug Application to inch its way through the bureaucratic maze, some observers believe. On the mind of the new man at FDA's helm are internal procedural changes to expedite NDA handling. At least six Congressional committees and subcommittees also will take their own look at the drug lag and no doubt will have some thoughts to offer.

* What do the executives who steer America's corporations fret over most in running their companies? Topping the list is concern over how to finance modernization of aging plants and equipment and the high costs and limited availability of energy, says a new survey. The executives are looking to government for tax incentives to help them pay for their necessary capital projects.

* The emergence of women in corporate boardrooms began as a trickle but is now reported to have evolved into a major trend. The number of women directors has increased 25 percent in just the last three years and many companies now have two or more females on their boards.

* The well-proven aptitude of the Japanese in electronics technology may soon be exhibited in what for them is a new arena—medical electronics. Companies now familiar to Americans for the TVs and toasters they produce are developing their own medical instruments with which they will invade the U. S. and elsewhere.

* Scientists at the University of Pennsylvania are anxiously awaiting the results of their first tests on a chemical they hope will protect normal human cells of cancer patients from assault by chemotherapeutic and X-ray treatments. The researchers are looking for a drug that will shield the normal cells without extending that protection to the cancers.

* The U. S. is the country that 219 multinational corporations call home but that's substantially fewer than in 1971, when 280 top-ranking companies were U. S.-based. The U. S. lead has slipped as multinationals in other parts of the world have gained in relative size, says a recent study.

The pause
that refreshes

Zbigniew Brzezinski, national
security advisor to former Presi-
dent Jimmy Carter, used to keep
a bottle of Listerine antiseptic
tucked discreetly behind the
potted ivy on one of the book-
shelves in his White House of-
fice, according to news accounts
that recently surfaced in a ma-
jor newspaper.

Brzezinski would sometimes
shock visitors by taking some of
the mouthwash, gargling it,
then spitting in into the plants,
notes the *Chicago Tribune*.

The reports did not mention
the condition of the potted ivy,
however.

Warner-Lambert World

PAUL DONCHEVSKY
Manager,
Corporate Communications

KEVIN M. KELLY
Editor,
Corporate Communications

Published monthly for employees of Warner-Lambert Company and its subsidiaries by Corporate Public Relations. Address all correspondence to Editor, Warner-Lambert World, Warner-Lambert Company, Morris Plains, N. J. 07950.

2

[L.C.]

HE GIVETH MORE GRACE

He giveth more grace when the burdens grow greater,
He sendeth more strength when the labors increase;
To added affliction He addeth His Mercy
To multiplied trials, His multiplied peace.

His Love has no limit; His grace has no measure;
His power no boundary known unto men;
For out of His infinite riches in Jesus
He giveth and giveth and giveth again.

—ANNIE JOHNSON FLINT

114